Aortic Valve Market is Forecasted to Attain Revenue of $13.6 Billion by 2025: P&S Market Research

NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Market Research, the global aortic valve market is forecasted to attain revenue of $13.6 billion by 2025, the market is mainly driven by increasing prevalence of valvular diseases, increasing demand for minimally invasive surgeries (MISs), rise in number of clinical trials for heart valves, and introduction of advanced implants.

The different types of valves available in the aortic valve market are transcatheter valves, sutureless valves and others. Among these, transcatheter valves attained the largest share of 58.8% in the market, in 2017. This leading position of the category is attributed to increasing initiatives for research activities for developing transcatheter valves and increasing number of clinical trials to study transcatheter valves. For instance, In December 2017, Edwards Lifesciences Corporation announced new data demonstrating the economic advantages of the company’s SAPIEN 3 transcatheter aortic valve.

Request to get the sample pages:

On the basis of type of surgery, aortic valve market is segmented into MIS and open surgery. The adoption of these valves for MISs is expected to grow at a faster CAGR of 13.7% during the forecast period. MISs causes lesser trauma to the patient and facilitate quicker recovery than invasive procedures such as open-heart surgeries. Due to reduced prices and advantages, there is an increase in the adoption of minimally invasive procedures, which contribute in the growth of the market.

The key end user in the aortic valve market includes hospitals, and others. Among these, hospitals registered the larger share, of 76.3%, in the market in 2017, owing to increasing number of patient population with valvular diseases in the hospitals.

During the forecast period, the aortic valve industry is expected to witness the fastest growth in demand in Asia-Pacific (APAC), at a CAGR of 13.0%, owing to the presence of large number of patient population with cardiovascular diseases, rising number of aortic valve replacement surgeries, growing medical tourism, and continuously improving healthcare infrastructure.

Moreover, economic development and rising healthcare expenditure are some of the factors that are expected to boost the APAC aortic valve market over the forecast period. Growing number of approvals for transcatheter valves by companies such as Edwards Lifesciences Corporation, Medtronic plc, and others is also expected to contribute in the growth of the market. For instance, in March 2018, LivaNova plc announced the first patient enrolment in the Perceval Valve clinical study for Chinese Registration (“PERFECT”) TRIAL. This pre-market, prospective, single-arm trial study is being conducted to demonstrate the safety and effectiveness of Perceval Valve.

Browse report overview with 153 tables and 46 figures spread through 161 pages and detailed TOC on "Aortic Valve Market by Product (Transcatheter Aortic Valve, Sutureless Valve), Surgery Type (Open, Minimally Invasive), by End User (Hospitals) by Geography (U.S., Canada, Germany, U.K., Russia, France, Italy, Spain, Japan, China, Taiwan, Hong Kong, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2025" at:

In December 2017, CryoLife Inc., announced the enrolment of patients for the company’s BioGlue clinical trial in China. The result from the trial will serve as the company’s regulatory submission to the Chinese Food and Drug Administration (CFDA) to gain approval to commercialize BioGlue in the country.

Globally, key players in the aortic valve industry are seeking for approvals to launch new products in the market. For instance, in February 2018, Edwards Lifesciences Corporation received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open surgery. In March 2018, LivaNova Plc received CE Mark approval for its Bicarbon aortic valves for use with low-dose anticoagulant therapy. This expanded indication of the company’s Bicarbon family of mechanical valves is based on evidence and results from the LOWERING-IT trial.

Some of the other key players operating in the aortic valve market are Medtronic plc and Boston Scientific Corporation.

More Reports by P&S Market Research

Bio-Based PET Market

APAC is expected to continue being the largest and fastest-growing bio-based PET market in the coming years. Increasing support from regulatory bodies to reduce greenhouse gas (GHG) emissions is one of the key factors driving the growth of the market in the region. According to the Australian Government Department of the Environment and Energy, under the 2015 Paris Agreement, plastic manufacturers in Australia are focusing toward the adoption of novel approaches in order to bring innovation in packaging materials and processes that can help reduce GHG emissions.

Breast Biopsy Devices Market

During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research-based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)



Connect with us: LinkedIn | Twitter | Google + | Facebook